Timeline › Pandemic, inflation & war
FDA approves Wegovy for obesity: the GLP-1 boom begins
Draft: not yet verifiedScience, invention & breakthrough technologyDemographics & society
Why it matters
Novo Nordisk becomes Europe's most valuable company (2023); Eli Lilly reaches a $1tn market value (Nov 2025); food, alcohol and medtech stocks hit
- Dalio lens
- Bubble seed: new-era technology
- Era
- Pandemic, inflation & war (2020–)
- Track
- Technology & science
- Asset classes
- Equities
- Verify via
- FDA
- Wikipedia
- Semaglutide (broader article)
- Date check
- broader article, not compared
Open in the interactive timeline, with its macro chartsSuggest a correction
Sources
References cited in the Wikipedia article, official and academic ones first.
- Wegovy (Novo Nordisk Pharmaceuticals Pty Ltd) (2022) (Official)
- FDA Approves Treatment for Serious Liver Disease Known as 'MASH' — U.S. Food and Drug Administration (FDA) (2025) (Official)
- FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 — U.S. Food and Drug Administration (FDA) (2014) (Official)
- FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight — U.S. Food and Drug Administration (FDA) (2024) (Official)
- Wegovy (semaglutide) injection, for subcutaneous use; Wegovy (semaglutide) tablets, for oral use — U.S. Food and Drug Administration (FDA) (Official)
← Tesla joins the S&P 500, then the largest addition everFusion ignition: the National Ignition Facility gets more energy out than the laser put in →
Previous and next events on the Technology & science track.
Cite this event
Wang, Y. (2026). FDA approves Wegovy for obesity: the GLP-1 boom begins (4 June 2021). In Macro-financial history, 1900–2026, event E0455. https://macrofinancialhistory.com/event/e0455/
@misc{mefh_e0455,
author = {Wang, Yuhui},
title = {FDA approves Wegovy for obesity: the GLP-1 boom begins},
howpublished = {Macro-financial history, 1900–2026, event E0455},
year = {2026},
url = {https://macrofinancialhistory.com/event/e0455/}
}